Inferior Cancer Survival for Men with Localized High-grade Prostate Cancer but Low Prostate-specific Antigen

Affiliations

• ¹ Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester, UK. Electronic address: christian.fankhauser@usz.ch.
• ² Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
• ³ Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
• ⁴ Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester, UK.
• ⁵ Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
• ⁶ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ⁷ Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna School of Medicine, Bologna, Italy.
• ⁸ Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
• ⁹ Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; McGraw/Patterson Center for Population Sciences, Boston, MA, USA.
• ¹⁰ Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
• ¹¹ Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.